90 research outputs found

    Rhizoma Peanut Based Cropping Systems for Dairy Effluent Spray Fields

    Get PDF
    Cropping schemes that efficiently utilize nutrients applied in dairy waste effluent sprayfields is needed to avoid ground water contamination. Three 12 month cropping systems were grown under dairy waste effluent irrigation: 1) corn-forage sorghum-rye (C-FSR), 2) corn-rhizoma peanut-rye (C-RP-R), and 3) rhizoma peanutrye (RP-R). With an effluent N loading rate of 403 kg ha-1 yr-1, 2-yr mean DM yield was 30.7 Mg ha-1 yr-1 for the C-FS-R system, 26.2 for C-RP-R, and 17.9 for RP-R. Nitrogen concentration for C and FS ranged from 9 to 14 g kg-1 while RP ranged from 24 to 35. The higher N concentration in RP forage compensated for the lower DM yield of the RP-R system, resulting in the highest N removal of the 3 systems

    Introduction to “Binary Binds”: Deconstructing Sex and Gender Dichotomies in Archaeological Practice

    Get PDF
    YesGender archaeology has made significant strides toward deconstructing the hegemony of binary categorizations. Challenging dichotomies such as man/woman, sex/gender, and biology/culture, approaches informed by poststructuralist, feminist, and queer theories have moved beyond essentialist and universalist identity constructs to more nuanced configurations. Despite the theoretical emphasis on context, multiplicity, and fluidity, binary starting points continue to streamline the spectrum of variability that is recognized, often reproducing normative assumptions in the evidence. The contributors to this special issue confront how sex, gender, and sexuality categories condition analytical visibility, aiming to develop approaches that respond to the complexity of theory in archaeological practice. The papers push the ontological and epistemological boundaries of bodies, personhood, and archaeological possibility, challenging a priori assumptions that contain how sex, gender, and sexuality categories are constituted and related to each other. Foregrounding intersectional approaches that engage with ambiguity, variability, and difference, this special issue seeks to “de-contain” categories, assumptions, and practices from “binding” our analytical gaze toward only certain kinds of persons and knowledges, in interpretations of the past and practices in the present

    US clinicians' perspectives on how mifepristone regulations affect access to medication abortion and early pregnancy loss care in primary care

    Get PDF
    Objective: Protocols including mifepristone are the most effective medication regimens for medication abortion and early pregnancy loss (EPL) management. Both can be safely and effectively offered in primary care settings. Despite mifepristone's excellent safety record, the United States (US) Food and Drug Administration (FDA) heavily regulates provision. This exploratory study examines US primary care clinicians' perspectives on the effects of mifepristone restrictions, including FDA regulations, on access to medication abortion and EPL management in primary care. Study design: In 2019, we conducted an online qualitative survey of US primary care clinicians recruited from six reproductive health-focused listservs. Open-ended questions queried about barriers to providing mifepristone and effects on patients when unable to access mifepristone in primary care. We iteratively coded and analyzed qualitative data using inductive thematic analysis. Results: Of our analytic sample of 113 respondents, one-third had mifepristone available in their current primary practice setting. Key barriers to provision stemmed from the FDA rule to stock and dispense mifepristone onsite, including logistical difficulties and resistance from health center leadership. Clinicians believed that lack of mifepristone in primary care resulted in negative patient experiences, including disrupted continuity of care, medically-unnecessary appointments, and undesired aspiration procedures. Conclusions: FDA regulations that inhibit mifepristone provision in primary care create structural barriers to provision. This may result in physical, emotional, and financial burdens for patients. Implications: When mifepristone is unavailable in primary care, some patients in need of abortion or EPL care may experience physical, emotional, and financial harms. Removing FDA restrictions is a critical step in reducing primary care barriers to mifepristone provision and improving access to timely, patient-centered medication abortion and EPL care

    Severe Enterobiasis in a Chimpanzee

    Full text link
    A severe case of enterobiasis was diagnosed in a chimpanzee. The primary lesions were an ulcerative enteritis and mesenteric lymphadenitis. Portions of nematodes identified as Enterobius sp. occurred in both locations. Few reports of this condition in chimpanzees were found in the literature. </jats:p

    Hospital Religious Affiliation and Emergency Contraceptive Prescribing Practices

    No full text
    With access to reproductive health care eroding, examination of prescribing of contraception, including emergency contraception (EC), is important. We examined whether working in a family practice affiliated with a religious institution changes the likelihood of a provider prescribing EC. Our survey asked about EC prescribing practices in a range of situations. As predicted, practitioners in non–religiously affiliated practices reported higher rates of prescribing EC than those in religiously affiliated practices. In both cases, however, the practitioners’ prescribing patterns were inadequate

    Beyond the Surface

    No full text
    Purpose: To describe rates of and reasons for follow-up among adolescents and adults receiving contraceptive implants in a Federally Qualified Health Center (FQHC). Methods: Retrospective comparison of patient-initiated implant-related contacts during the 6 months postinsertion among adolescents (110) and adults (154) who had implants placed at a FQHC network. Results: Forty percent of adolescents and 26% of adults initiated follow-up ( P = .016). Bleeding changes and discussing removal were the most common reasons for follow-up for both groups. Adolescents (5.5%) and adults (9.0%) had similar removal rates ( P = .348). However, among patients who discussed implant removal, adults were more likely to have removals compared with adolescents ( P = .002). Conclusions: Other FQHCs may anticipate a similar experience to ours, where adolescents may be more likely than adults to initiate implant-related follow up, with removal rates of less than 10% at 6 months. Further study of physician decision making and patient autonomy regarding implantable contraception removal requests is warranted
    corecore